| |
| |
|
| Insider
Information: |
Dolsten Mikael |
| Relationship: |
Director |
| City: |
Madison |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
327,440 |
|
|
Indirect Shares
|
1,981 |
|
|
| Direct
Value |
$9,581,886 |
|
|
|
Indirect Value
|
$54,319 |
|
|
| Total
Shares |
329,421 |
|
|
| Total
Value |
$9,636,205 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -16.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
President R&D |
2024-02-28 |
321,729 |
2024-02-28 |
1,981 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
5,711 |
2021-09-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-02-24 |
4 |
D |
$35.98 |
$3,954,664 |
D/D |
(109,493) |
115,772 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-02-28 |
4 |
OE |
$27.37 |
$5,425,774 |
D/D |
198,238 |
293,352 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-02-28 |
4 |
D |
$35.70 |
$5,681,080 |
D/D |
(158,482) |
134,870 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-03-02 |
4 |
S |
$35.85 |
$501,398 |
D/D |
(13,986) |
120,884 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-03-09 |
4 |
S |
$36.55 |
$2,550,394 |
D/D |
(69,699) |
51,185 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-09-13 |
4 |
OE |
$21.03 |
$4,462,167 |
D/D |
181,712 |
234,299 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-01-31 |
4 |
OE |
$27.37 |
$3,751,425 |
D/D |
125,968 |
362,051 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-02-23 |
4 |
D |
$42.96 |
$2,344,241 |
D/D |
(54,568) |
310,078 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
96,183 |
406,261 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-02-27 |
4 |
D |
$42.93 |
$3,167,075 |
D/D |
(73,773) |
332,488 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-03-01 |
4 |
OE |
$30.59 |
$3,328,057 |
D/D |
106,191 |
438,679 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-03-01 |
4 |
S |
$43.56 |
$4,376,852 |
D/D |
(100,471) |
338,208 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-03-04 |
4 |
S |
$43.52 |
$2,136,293 |
D/D |
(49,082) |
289,126 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-02-26 |
4 |
D |
$34.72 |
$1,312,138 |
D/D |
(37,792) |
307,961 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
45,566 |
345,753 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-02-28 |
4 |
D |
$33.42 |
$1,318,285 |
D/D |
(39,446) |
268,515 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-05-18 |
4 |
S |
$37.75 |
$3,602,681 |
D/D |
(95,353) |
174,918 |
0 |
% |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-25 |
4 |
D |
$33.82 |
$956,125 |
D/D |
(28,271) |
156,568 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-25 |
4/A |
D |
$33.82 |
$956,125 |
D/D |
(28,271) |
161,568 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-27 |
4 |
D |
$33.49 |
$798,435 |
D/D |
(23,841) |
137,727 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2021-09-22 |
4 |
A |
$172.44 |
$97,773 |
D/D |
567 |
567 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-11-11 |
4 |
S |
$50.28 |
$3,000,647 |
D/D |
(59,664) |
279,842 |
0 |
% |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-11-11 |
4 |
OE |
$22.89 |
$5,014,926 |
D/D |
199,548 |
339,506 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-12-17 |
4 |
OE |
$30.17 |
$2,147,712 |
D/D |
71,187 |
351,637 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2022-02-23 |
4 |
D |
$46.87 |
$1,395,179 |
D/D |
(29,767) |
323,862 |
0 |
- |
|
61 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
